T1 Condition 304 306 PC
T2 Protein 1428 1430 GR
T3 Biomarker 1401 1403 TF
T4 Protein 504 506 GR
T5 Protein 244 246 GR
T6 Protein 1173 1178 STAT1
T7 Biomarker 1100 1102 TF
T8 Protein 790 792 GR
T9 Condition 1466 1474 prostate
T10 Protein 1166 1171 Elk-1
T11 Protein 377 379 GR
T12 Protein 736 741 c-Myc
T13 Protein 1148 1157 CEBPalpha
T14 Condition 1330 1332 PC
T15 Condition 77 92 prostate cancer
T16 Gene 687 690 p27
T17 Protein 1136 1139 p53
T18 Condition 830 832 PC
T19 Protein 1043 1045 GR
T20 Gene 711 720 cyclin D1
T21 Organism 464 474 lentiviral
T22 Condition 578 630 monolayer cultures and blocked anchorage-independent
T23 Protein 174 176 GR
T24 Condition 322 327 tumor
T25 Level 446 451 LNCaP
T26 Protein 1120 1123 SRF
T27 Protein 1125 1134 NF-kappaB
T28 Level 446 457 LNCaP cells
T29 Protein 959 963 MAPK
T30 Protein 1521 1544 transcriptional factors
T31 Condition 335 337 PC
T32 Biomarker 1114 1118 AP-1
T33 Gene 679 682 p21
T34 Level 498 503 LNCaP
T35 Condition 77 85 prostate
T36 Intervention 207 223 prostate samples
T37 Protein 1077 1098 transcription factors
T38 Biomarker 1142 1144 TF
T39 Level 498 512 LNCaP-GR cells
T40 Biomarker 1141 1146 ATF-2
T41 Condition 207 215 prostate
T42 Condition 181 183 PC
T43 Level 335 348 PC cell lines
T44 Protein 407 409 GR
T45 Level 1401 1404 TFs
T46 Condition 319 328 PC tumors
T47 Gene 149 172 glucocorticoid receptor
T48 Condition 94 96 PC
T49 Condition 1446 1451 tumor
T50 Condition 319 321 PC
T51 Protein 892 894 GR
T52 Gene 946 958 MAP-kinases 
T53 Protein 1159 1164 Ets-1
T54 Protein 1223 1227 MAPK
T55 Level 360 365 LNCaP
T56 Gene 1264 1290 hepsin and AMACR promoters
R1 Relation Arg1:T23 Arg2:T42
